Clinical trial

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

NCT00361543

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE4

Study timeline

Study start (unknown)2006-08-01Date precision: month

Registry last updated2015-01-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Interventions

Raloxifene hydrochlorideDRUG · verified · RxNorm: raloxifene hydrochloride

Lactose CapsulesOTHER

Sponsors & collaborators

The Alfredlead sponsor

Stanley Medical Research Institutecollaborator

National Health and Medical Research Council, Australiacollaborator

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00361543 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.